{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.2582","upperLimit":"0.5173","value":"0.3888"},{"groupId":"OG001","lowerLimit":"0.1873","upperLimit":"0.8064","value":"0.5486"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"11"}],"units":"Participants"}],"description":"Estimated 4-year survival, where survival is calculated as the time from study enrollment to death from any cause or last follow-up alive whichever occurs first. Kaplan-Meier method is used for estimation. Patients alive at last contact are censored.","dispersionType":"95% Confidence Interval","groups":[{"description":"Infants (\\<36 months of age) with tumor histology and immunohistochemical analysis diagnostic of AT/RT.","id":"OG000","title":"Stratum I"},{"description":"Older children (greater than 36 months of age) with tumor histology and immunohistochemical analysis diagnostic of AT/RT.","id":"OG001","title":"Stratum III"}],"paramType":"NUMBER","populationDescription":"One patient was ineligible in stratum I and one patient was ineligible in stratum III. There were no patients enrolled in Stratum 2 or 4.","reportingStatus":"POSTED","timeFrame":"Up to 4 years after study enrollment","title":"Overall Survival (OS)","type":"PRIMARY","unitOfMeasure":"Estimated Probability"}